Alternative EBNA1 expression in organ transplant patients

Journal of Medical Virology

Volumn 76, Issue 3, 2005, Pages 378-385

  Berggren, Malin Å M ^a   Isaksson, Åsa ^a   Larsson, Ulrica ^a   Nilsson, Folke ^a   Nyström, Ulla ^a   Ekman, Tor ^a   Löfvenmark, Jane ^a   Kicksten, Anne ^a  

^a SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Alternative splice; EBV; IRES; PTLD

Indexed keywords

AZATHIOPRINE; CYCLOSPORIN; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISOLONE; PREDNISONE; TACROLIMUS;

5' UNTRANSLATED REGION; ADOLESCENT; ADULT; ALTERNATIVE RNA SPLICING; ANIMAL CELL; ARTICLE; B LYMPHOCYTE; BLOOD; CHILD; CONTROLLED STUDY; EBNA1 GENE; EPSTEIN BARR VIRUS; EXON; FEMALE; GENE EXPRESSION; GENETIC TRANSFECTION; HIGH RISK POPULATION; HUMAN; HUMAN CELL; IMMUNOSUPPRESSIVE TREATMENT; IN VIVO STUDY; INTERNAL RIBOSOME ENTRY SITE; LYMPHOPROLIFERATIVE DISEASE; MAJOR CLINICAL STUDY; MALE; NONHUMAN; NUCLEOTIDE SEQUENCE; ORGAN TRANSPLANTATION; PROMOTER REGION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA TRANSLATION; SIDE EFFECT; VIRUS GENE; WESTERN BLOTTING;

5' UNTRANSLATED REGIONS; ADOLESCENT; ADULT; ALTERNATIVE SPLICING; BLOTTING, WESTERN; CELL LINE; CHILD; CHILD, PRESCHOOL; EPSTEIN-BARR VIRUS NUCLEAR ANTIGENS; EXONS; FEMALE; HERPESVIRUS 4, HUMAN; HUMANS; INFANT; LEUKOCYTES; MALE; MIDDLE AGED; ORGAN TRANSPLANTATION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; RNA, VIRAL; SWEDEN; TRANSFECTION;

EID: 20044364369     PISSN: 01466615     EISSN: None     Source Type: Journal    
DOI: 10.1002/jmv.20369     Document Type: Article

References (37)

1. Ben-Bassat H, Goldblum N, Mitrani S, Goldblum T, Yoffey JM, Cohen MM, Bentwich Z, Ramot B, Klein E, Klein G. 1977. Establishment in continuous culture of a new type of lymphocyte from a "Burkitt like" malignant lymphoma (line D.G.-75). Int J Cancer 19:27-33.
2. Borestrom C, Zetterberg H, Liff K, Rymo L. 2003. Functional interaction of nuclear factor y and sp1 is required for activation of the Epstein-Barr virus C promoter. J Virol 77:821-829.
3. Brink AA, Meijer CJ, Nicholls JM, Middeldorp JM, van den Brule AJ. 2001. Activity of the EBNA1 promoter associated with lytic replication (Fp) in Epstein-Barr virus associated disorders. Mol Pathol 54:98-102.
4. Isaksson A, Berggren M, Kicksten A. 2003. Epstein-Barr virus U leader exon contains an internal ribosome entry site. Oncogene 22:572-581.
5. Kieff E, Rickinson AB. 2001. Epstein-Barr virus and its replication. In: Fields BN, Knipe PM, Howley PM, editors. Fields virology. 4th edn. Philadelphia: Lippincott-Raven Publishers, pp 2511-2573.
6. Klein G, Yefenof E, Falk K, Westman A. 1978. Relationship between Epstein-Barr virus (EBV)-production and the loss of the EBV receptor/complement receptor complex in a series of sublines derived from the same original Burkitt's lymphoma. Int J Cancer 21:552-560.
7. Lear AL, Rowe M, Kurilla MG, Lee S, Henderson S, Kieff E, Rickinson AB. 1992. The Epstein-Barr virus (EBV) nuclear antigen 1 BamHI F promoter is activated on entry of EBV-transformed B cells into the lytic cycle. J Virol 66:7461-7468.
8. Marechal V, Dehee A, Chikhi-Brachet R, Piolot T, Coppey-Moisan M, Nicolas JC. 1999. Mapping EBNA-1 domains involved in binding to metaphase chromosomes. J Virol 73:4385-4392.
9. Martinez-Salas E. 1999. Internal ribosome entry site biology and its use in expression vectors. Curr Opin Biotechnol 10:458-464.
10. Martinez-Salas E, Ramos R, Lafuente E, Lopez de Quinto S. 2001. Functional interactions in internal translation initiation directed by viral and cellular IRES elements. J Gen Virol 82:973-984.
11. Miller G, Lipman M. 1973. Release of infectious Epstein-Barr virus by transformed marmoset leukocytes. Proc Natl Acad Sci USA 70:190-194.
12. Miyashita EM, Yang B, Babcock GJ, Thorley-Lawson DA. 1997. Identification of the site of Epstein-Barr virus persistence in vivo as a resting B cell. J Virol 71:4882-4891.
13. Morris DR, Geballe AP. 2000. Upstream open reading frames as regulators of mRNA translation. Mol Cell Biol 20:8635-8642.
14. Newton DC, Bevan SC, Choi S, Robb GB, Millar A, Wang Y, Marsden PA. 2003. Translational regulation of human neuronal nitric-oxide synthase by an alternatively spliced 5′-untranslated region leader exon. J Biol Chem 278:636-644.
15. Nonkwelo C, Henson EB, Sample J. 1995. Characterization of the Epstein-Barr virus Fp promoter. Virology 206:183-195.
16. Qu L, Rowe DT. 1995. Epstein-Barr virus latent messages with shuffled leader exons: Remnants of circumgenomic transcription? J Virol 69:1000-1008.
17. Qu L, Green M, Webber S, Reyes J, Ellis D, Rowe D. 2000. Epstein-Barr virus gene expression in the peripheral blood of transplant recipients with persistent circulating virus loads. J Infect Dis 182:1013-1021.
18. Ricksten A, Olsson A, Andersson T, Rymo L. 1988. The 5′ flanking region of the gene for the Epstein-Barr virus-encoded nuclear antigen 2 contains a cell type specific cis-acting regulatory element that activates transcription in transfected B-cells. Nucleic Acids Res 16:8391-8410.
19. Sachs AB, Sarnow P, Hentze MW. 1997. Starting at the beginning, middle, and end: Translation initiation in eukaryotes. Cell 89:831-838.
20. Sambrook J, Russell DW. 2001. Molecular cloning. Cold spring harbor, New York: Cold spring harbor laboratory press, pp 1.1-1.138.
21. Sample J, Hummel M, Braun D, Birkenbach M, Kieff E. 1986. Nucleotide sequences of mRNAs encoding Epstein-Barr virus nuclear proteins: A probable transcriptional initiation site. Proc Natl Acad Sci USA 83:0096-5100.
22. Sample J, Henson EB, Sample C. 1992. The Epstein-Barr virus nuclear protein 1 promoter active in type I latency is autoregulated. J Virol 66:4634-4661.
23. Schaefer BC, Strominger JL, Speck SH. 1995. Redefining the Epstein-Barr virus-encoded nuclear antigen EBNA-1 gene promoter and transcription initiation site in group I Burkitt lymphoma cell lines. Proc Natl Acad Sci USA 92:10565-10569.
24. Schaefer BC, Paulson E, Strominger JL, Speck SH. 1997. Constitutive activation of Epstein-Barr virus (EBV) nuclear antigen 1 gene transcription by IRF1 and IRF2 during restricted EBV latency. Mol Cell Biol 17:873-886.
25. Shin D, Park S, Park C. 2003. A splice variant acquiring an extra transcript leader region decreases the translation of glutamine synthetase gene. Biochem J 374:175-184.
26. Sonenberg N. 1993. Remarks on the mechanism of ribosome binding to eukaryotic mRNAs. Gene Expr 3:317-323.
27. Speck SH, Strominger JL. 1985. Analysis of the transcript encoding the latent Epstein-Barr virus nuclear antigen I: A potentially polycistronic message generated by long-range splicing of several exons. Proc Natl Acad Sci USA 82:8305-8309.
28. Tao Q, Robertson KD, Manns A, Hildesheim A, Ambinder RF. 1998. The Epstein-Barr virus major latent promoter Qp is constitutively active, hypomethylated, and methylation sensitive. J Virol 72:7075-7083.
29. Theil EC. 1990. Ferritin mRNA translation, structure, and gene transcription during development of animals and plants. Enzyme 44:68-82.
30. Thorley-Lawson DA, Babcock GJ. 1999. A model for persistent infection with Epstein-Barr virus: The stealth virus of human B cells. Life Sci 65:1433-1453.
31. Tsai CN, Liu ST, Chang YS. 1995. Identification of a novel promoter located within the Bam HI Q region of the Epstein-Barr virus genome for the EBNA 1 gene. DNA Cell Biol 14:767-776.
32. van der Velden AW, Thomas AA. 1999. The role of the 5′ untranslated region of an mRNA in translation regulation during development. Int J Biochem Cell Biol 31:87-106.
33. Wagner HJ, Wessel M, Jabs W, Smets F, Fischer L, Offner G, Bucsky P. 2001. Patients at risk for development of posttransplant lymphoproliferative disorder: Plasma versus peripheral blood mononuclear cells as material for quantification of Epstein-Barr viral load by using real-time quantitative polymerase chain reaction. Transplantation 72:1012-1019.
34. Woisetschlaeger M, Yandava CN, Furmanski LA, Strominger JL, Speck SH. 1990. Promoter switching in Epstein-Barr virus during the initial stages of infection of B lymphocytes. Proc Natl Acad Sci USA 87:1725-1729.
35. Yates JL, Warren N, Sugden B. 1985. Stable replication of plasmids derived from Epstein-Barr virus in various mammalian cells. Nature 313:812-815.
36. Yin Y, Manoury B, Fahraeus R. 2003. Self-inhibition of synthesis and antigen presentation by Epstein-Barr virus-encoded EBNA1. Science 301(5638):1371-1374.
37. Zetterberg H, Stenglein M, Jansson A, Ricksten A, Rymo L. 1999. Relative levels of EBNA1 gene transcripts from the C/W, F and Q promoters in Epstein-Barr virus-transformed lymphoid cells in latent and lytic stages of infection. J Gen Virol 80:457-466.